Navigation Links
PRA Holdings Announces Proposed Private Offering of $375 Million Senior Notes Due 2023
Date:9/11/2013

RALEIGH, N.C., Sept. 11, 2013 /PRNewswire/ -- PRA Holdings, Inc. ("PRA"), a leading global contract research organization providing outsourced clinical development services to the biotechnology and pharmaceutical industries, announced today that Pinnacle Merger Sub, Inc., which will be merged with and into PRA Holdings, Inc. upon consummation of the offering, intends, subject to market and other conditions, to offer $375,000,000 aggregate principal amount of its Senior Notes due 2023 (the "Notes") in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The Notes will be guaranteed on a senior basis by all of PRA's existing and future direct and indirect domestic subsidiaries that guarantee obligations under its senior secured credit facilities. This offering is expected to be made in connection with the proposed acquisition of PRA and RPS Parent Holding Corp. ("RPS"), a leading global contract research organization providing clinical development services to the biotechnology and pharmaceutical industry, by entities affiliated with Kohlberg Kravis Roberts & Co. L.P. (the "Sponsor"). The net proceeds from this offering will be used to finance in part the acquisition of PRA and RPS by the Sponsor, the repayment of existing debt of PRA and RPS and the payment of fees and expenses in connection with such transactions.

The Notes and the related guarantees will be offered only to qualified institutional buyers in reliance on the exemption from registration set forth in Rule 144A under the Securities Act, and outside the United States to non-U.S. persons in reliance on the exemption from registration set forth in Regulation S under the Securities Act. The Notes and the related guarantees have not been registered under the Securities Act, or the securities laws of any state or other jurisdiction, and may not be offered or sold in the United States without registration or an applicable exemption from the Securities Act and applicable state securities or blue sky laws and foreign securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, any securities, nor shall there be any sales of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.


'/>"/>
SOURCE PRA Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
2. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
3. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
4. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
5. Accident Fund Holdings Aims to Improve Control of Drug Utilization and Quality of Care with Change in Pharmacy Benefit Manager
6. China Kanghui Holdings Reports First Quarter 2012 Financial Results
7. InfuSystem Holdings Modifies Bylaws to Align with Corporate Governance Best Practices
8. InfuSystem Holdings, Inc. Terminates "Poison Pill" Plan
9. Golden Meditech Holdings Limited Announces 2011/ 2012 Annual Results
10. Hill-Rom Holdings, Inc. Hosts Fiscal 2012 Third Quarter Earnings Conference Call and Webcast
11. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
(Date:6/24/2016)... Arizona (PRWEB) , ... June 24, 2016 , ... ... practice, is supporting the upcoming 2016 Miss Arizona pageant as its official Medspa ... serves Scottsdale, Tempe, Mesa, and Chandler, Arizona. , Dr. Olson says the ...
Breaking Medicine News(10 mins):